Sodium glucose cotransporter‐2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function

AIMS: Recent studies indicated that sodium glucose cotransporter‐2 inhibitors (SGLT2i) reduced heart failure hospitalization in patients with type 2 diabetes mellitus (T2DM). However, whether SGTL2i can improve left ventricular (LV) systolic and diastolic function remained unclear. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yi‐Hsin, Hsu, Tzyy‐Jer, Wang, Chun‐Li, Kao, Yi‐Wei, Huang, Chien‐Ying, Chu, Pao‐Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524050/
https://www.ncbi.nlm.nih.gov/pubmed/32627380
http://dx.doi.org/10.1002/ehf2.12877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524050/
https://www.ncbi.nlm.nih.gov/pubmed/32627380
http://dx.doi.org/10.1002/ehf2.12877

Ejemplares similares